Rank #1: Inflammatory Bowel Disease: Key Signs and Symptoms
From the Crohn's & Colitis Foundation's Take Steps Walk in Philadelphia, host Rhondell Domilici talks with Dr. Adam Kaufman, Gastroenterologist, and internist at Mainline Gastroenterology Associates, about the signs and symptoms of Inflammatory Bowel Disease.
Rank #2: Biologics For Inflammatory Bowel Disease: Maximizing Benefits, Avoiding Complications
Host: Lea Ann Chen, MD Guest: Gary Lichtenstein, MD Recorded on location at the Crohn’s & Colitis Foundation’s Annual Meeting in Orlando, host Dr. Lea Ann Chen, Assistant Professor of Medicine at New York University, discusses potential complications of biologics with Dr. Gary Lichtenstein, Professor of Medicine at the Hospital of the University of Pennsylvania.
Rank #3: IBD Preventive Care: Clinical Priorities for Best Patient Outcomes
Host: Brian P. McDonough, MD, FAAFP Guest: Adam Ehrlich, MD, MPH Guest: John D. Betteridge, MD From the ReachMD studios in Fort Washington, Pennsylvania, host Dr. Brian McDonough leads an expert panel focusing on preventive care for IBD patients. Joining the expert panel are: Dr. Adam C. Ehrlich, Assistant Professor of Medicine at the Lewis Katz School of Medicine at Temple University and Co-Medical Director of the Temple Inflammatory Bowel Disease Program, and Dr. John D. Betteridge, Gastroenterologist at Lancaster General Hospital and Regional Gi Medical Center. Drs. Ehrlich and Betteridge discuss the issues surrounding IBD with a focus on preventative care in patients. Discussion points include micronutrient deficiencies, immunosuppression, methods to maintain a well-balanced nutrient-rich diet, and communication strategies between PCPs and GI specialists to improve patient care.
Rank #4: What IBD Professionals can Expect from the 2019 Annual Crohn’s & Colitis Congress
The Crohn’s & Colitis Foundation, in partnership with the American Gastroenterological Association, will hold their 2nd Annual Congress from February 7 - 9, 2019 at the Bellagio Hotel in Las Vegas. To give you an inside look into the premier meeting for all IBD professionals and researchers, here’s a special message from Michael Osso, President & CEO of the Crohn’s & Colitis Foundation. For more information and to register, please go to: www.crohnscolitiscongress.org.
Rank #5: Redefining Mucosal Healing in IBD: Updated Goals of Therapy
Host: Lea Ann Chen, MD Guest: Hans Herfarth, MD Recorded on location at the Crohn’s & Colitis Foundation’s Annual Meeting in Orlando, host Dr. Lea Ann Chen, Assistant Professor of Medicine at New York University, discusses goals of therapy in IBD with Dr. Hans Herfarth, Professor of Medicine at University of North Carolina School of Medicine.
Rank #6: Indications for Surgery for Inflammatory Bowel Disease
Guest: Michael E. Kwiatt, MD From the Crohn's & Colitis Foundation's Take Steps walk in Philadelphia, host Rhondell Domilici talks with Dr. Michael Kwiatt, a surgeon at Cooper University Health Care, about the indications and benefits of surgery for patients with Inflammatory Bowel Disease.
Rank #7: Importance of Nutrition in Managing Inflammatory Bowel Disease
From the Crohn's & Colitis Foundation's Take Steps Walk in Philadelphia, host Rhondell Domilici talks with Dr. Lindsey Albenberg, Gastroenterologist in the division of Gastroenterology, Hepatology and Nutrition at the Children's Hospital of Philadelphia, about the value of nutrition in managing inflammatory bowel disease.
Rank #8: Highlights from the Crohn’s & Colitis Foundation Perspectives Series
Hear from experts, patients, and caregivers as they discuss the latest in IBD in the Crohn’s & Colitis Foundation Perspectives series.
Rank #9: Clinical Trials in IBD: Advancing Science, Enhancing Patient Care
Host: Caren Heller, MD Guest: William J. Sandborn, MD Clinical trials, among several critical purposes, are essential for the evaluation and approval of medication options for patients living with inflammatory bowel diseases. Despite this, only 6% of clinical trials are completed on time due to unfulfilled enrollment, often stemming to communication barriers between clinicians and patients. Host Dr. Caren Heller, Chief Scientific Officer at the Crohn's & Colitis Foundation, sits down with Dr. William Sandborn, Professor of Medicine and Adjunct Professor of Surgery at the University of California-San Diego, about the many benefits that clinical trials can provide for IBD patients.
Rank #10: A Message from the President & CEO of Crohn’s & Colitis Foundation
Hear from Michael Osso, President and CEO of the Crohn’s & Colitis Foundation, as he talks about the Crohn’s & Colitis Foundation Perspectives series on ReachMD.
Rank #11: Optimizing Growth in Pediatric Inflammatory Bowel Disease
Guest: KT Park, MD Recorded on location at the Crohn’s & Colitis Foundation's Annual Meeting in Orlando, host Dr. Sophie Balzora, Crohn's & Colitis Foundation Reach-IBD member and faculty advisor of the Greater New York Chapter Fellows' Education Committee, discusses general strategies for clinicians and families to optimize growth in pediatric IBD with Dr. K.T. Park, Assistant Professor of Pediatric Gastroenterology at Stanford University School of Medicine & Co-Director of Stanford Children’s Inflammatory Bowel Disease Center.
Rank #12: Improving Surveillance for Colorectal Cancer in IBD Patients
Host: Caren Heller, MD Guest: Francis Farraye, MD Studies have shown that certain patients living with inflammatory bowel disease, or IBD, have a higher risk of developing colorectal cancer. In fact, IBD ranks as the third highest risk factor for the development of colorectal cancer. Host Dr. Caren Heller, Chief Scientific Officer at the Crohn's & Colitis Foundation, sits down with Dr. Francis Farraye, gastroenterologist and Professor of Medicine and Co-Director of the Center for Digestive Disorders at Boston University School of Medicine. The two talk about making guidelines on endoscopic screening, surveillance, and detection of dysplasia more beneficial to IBD patients.
Rank #13: Key Surgical Indications for IBD Patients
Host: Lea Ann Chen, MD Guest: Miguel Regueiro, MD Recorded on location at the Crohn’s & Colitis Foundation’s Annual Meeting in Orlando, host Dr. Lea Ann Chen, Assistant Professor of Medicine at New York University, discusses surgical indications for the IBD patient with Dr. Miguel Regueiro, Professor of Medicine at the University of Pittsburgh.
Rank #14: Inflammatory Bowel Disease Emergencies: Toward Faster Identification and Management
Host: Laura Wingate Guest: Kim Isaacs, MD Some of the most severe complications associated with ulcerative colitis are toxic megacolon, bleeding, fulminant colitis, and perforation of the bowel, while abscesses, intestinal bleeding, fistulas are more commonly associated with Crohn’s disease. While the development of emergency complications in IBD is uncommon, it can be life-threatening and result in permanent organ damage. On this episode focusing on IBD emergencies, host Laura Wingate, Vice President of Education, Support, and Advocacy at the Crohn’s & Colitis Foundation, welcomes gastroenterologist Dr. Kim Isaacs, Professor of Medicine and Co-director of the UNC Multidisciplinary Center for IBD Research and Treatment at University of North Carolina–Chapel Hill.
Rank #15: Predictors of Emergency Department Use by Persons with Inflammatory Bowel Diseases: A Population-Based Study
Predictors of Emergency Department Use by Persons with Inflammatory Bowel Diseases: A Population-based Study Nugent, Zoann PhD; Singh, Harminder MD, MPH; Targownik, Laura E. MD; Strome, Trevor MS; Snider, Carolyn MD, MPH; Bernstein, Charles N. MD Background: To describe the patterns and predictors of emergency department (ED) attendance and post-ED hospitalization by persons with inflammatory bowel disease (IBD). Methods: We linked the University of Manitoba IBD Epidemiology Database with the Emergency Department Information System of the Winnipeg Regional Health Authority to determine the rates of presentation to the ED by persons with IBD from January 01, 2009 to March 31, 2012. Incident cases were diagnosed during the study period and all others were considered prevalent cases. Multivariate logistic regression was used to determine predictors of attendance in the ED and for hospitalization within 2 days of ED attendance. Results: The study population included 300 incident and 3394 prevalent IBD cases, of whom 76% and 49%, respectively, attended the ED at least once during the study period. Incident cases with Crohn's disease or with a history of opioid use were more likely to attend the ED. Those who had seen a gastroenterologist within the year before diagnosis were less likely to ...